Literature DB >> 8120033

Cyclic AMP-dependent phosphorylation of an immunoaffinity-purified homotetrameric inositol 1,4,5-trisphosphate receptor (type I) increases Ca2+ flux in reconstituted lipid vesicles.

S Nakade1, S K Rhee, H Hamanaka, K Mikoshiba.   

Abstract

We established a novel method to isolate a single type of inositol 1,4,5-trisphosphate receptor (IP3R) among the heterogeneous population of receptors to study the regulatory mechanism of Ca2+ release. We raised in the rabbit a polyclonal antibody against synthetic peptide corresponding to amino acids 2736-2747 (pep 6) of type I IP3R (IP3-R-I) that is most abundant in cerebellum. We purified IP3R-I from a 1% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonic acid solubilized mouse cerebellar microsomal fraction by immunoaffinity chromatography on an anti-pep 6 antibody-Sepharose 4B column with specific elution by the pep 6 peptide (GHPPHMNVNPQQ) of the IP3R-I C terminus. Immunoaffinity-purified IP3R reconstituted into lipid vesicles formed a homotetramer structure. Monoclonal antibody 18A10, which partially blocks the Ca2+ release from cerebellar microsome, almost completely inhibited IP3-induced 45Ca2+ influx into proteoliposomes, whereas monoclonal antibody that recognizes other regions did not inhibit Ca2+ influx. Both the rate and extent of 45Ca2+ influx into proteoliposomes increased 20% after incubation with the catalytic subunit of cyclic AMP-dependent protein kinase, accompanied by stoichiometric phosphorylation of IP3R protein.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8120033

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  43 in total

1.  Carbonic anhydrase-related protein is a novel binding protein for inositol 1,4,5-trisphosphate receptor type 1.

Authors:  Junji Hirota; Hideaki Ando; Kozo Hamada; Katsuhiko Mikoshiba
Journal:  Biochem J       Date:  2003-06-01       Impact factor: 3.857

2.  Sparks and puffs in oligodendrocyte progenitors: cross talk between ryanodine receptors and inositol trisphosphate receptors.

Authors:  L L Haak; L S Song; T F Molinski; I N Pessah; H Cheng; J T Russell
Journal:  J Neurosci       Date:  2001-06-01       Impact factor: 6.167

Review 3.  Pharmacology of signaling induced by dopamine D(1)-like receptor activation.

Authors:  Ashiwel S Undieh
Journal:  Pharmacol Ther       Date:  2010-06-12       Impact factor: 12.310

4.  InsP3R-associated cGMP kinase substrate determines inositol 1,4,5-trisphosphate receptor susceptibility to phosphoregulation by cyclic nucleotide-dependent kinases.

Authors:  Wataru Masuda; Matthew J Betzenhauser; David I Yule
Journal:  J Biol Chem       Date:  2010-09-27       Impact factor: 5.157

5.  Interplay of Ca2+ and cAMP signaling in the insulin-secreting MIN6 beta-cell line.

Authors:  Luis R Landa; Mark Harbeck; Kelly Kaihara; Oleg Chepurny; Kajorn Kitiphongspattana; Oliver Graf; Viacheslav O Nikolaev; Martin J Lohse; George G Holz; Michael W Roe
Journal:  J Biol Chem       Date:  2005-06-29       Impact factor: 5.157

Review 6.  Inositol trisphosphate receptor Ca2+ release channels.

Authors:  J Kevin Foskett; Carl White; King-Ho Cheung; Don-On Daniel Mak
Journal:  Physiol Rev       Date:  2007-04       Impact factor: 37.312

7.  cAMP-regulated guanine nucleotide exchange factor II (Epac2) mediates Ca2+-induced Ca2+ release in INS-1 pancreatic beta-cells.

Authors:  G Kang; O G Chepurny; G G Holz
Journal:  J Physiol       Date:  2001-10-15       Impact factor: 5.182

8.  cGMP inhibits IP3-induced Ca2+ release in intact rat megakaryocytes via cGMP- and cAMP-dependent protein kinases.

Authors:  S Tertyshnikova; X Yan; A Fein
Journal:  J Physiol       Date:  1998-10-01       Impact factor: 5.182

9.  Modulation of type 1 inositol (1,4,5)-trisphosphate receptor function by protein kinase a and protein phosphatase 1alpha.

Authors:  Tie-Shan Tang; Huiping Tu; Zhengnan Wang; Ilya Bezprozvanny
Journal:  J Neurosci       Date:  2003-01-15       Impact factor: 6.167

10.  The calmodulin-binding domain in the mouse type 1 inositol 1,4,5-trisphosphate receptor.

Authors:  M Yamada; A Miyawaki; K Saito; T Nakajima; M Yamamoto-Hino; Y Ryo; T Furuichi; K Mikoshiba
Journal:  Biochem J       Date:  1995-05-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.